Cooper Companies

COO · Health Care · Market cap $14.1B

Q2 FY26 Apr 30, 2026 reported Jun 5, 2026

Revenue$1.1B +8% year over year

Gross profit$0.7B

Operating profit$0B

Net profit$-0.1B -7% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Apr 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	1.1	100%	+8%
CooperVision	0.7	64%
CooperSurgical	0.4	36%
Cost of revenue	−0.3	27%
Gross profit	0.7	68% margin	+0pp
Research & development	−0	4%	−1pp
SG&A	−0.8	63%	+23pp
Other	−0	4%	+0pp
Operating profit	0	-3% margin	−21pp
Interest & other costs	−0.1
Net profit	-0.1	-7%	−16pp

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Jul 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.1	100%	+6%
Sphere, other	0.4	36%	+3%
Toric and multifocal	0.4	36%	+10%
Office and surgical	0.2	18%	+3%
Fertility	0.1	9%	+6%
Cost of revenue	−0.4	36%
Gross profit	0.7	65% margin	−1pp
Research & development	−0	4%	+0pp
SG&A	−0.4	40%	+2pp
Other	−0.1	5%	+0pp
Operating profit	0.2	17% margin	−3pp
Tax	−0.1
Net profit	0.1	9%	−1pp

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Apr 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1	100%	+6%
Sphere, other	0.3	30%
Toric and multifocal	0.3	30%
Office and surgical	0.2	20%
Fertility	0.1	10%
Cost of revenue	−0.3	30%
Gross profit	0.7	68% margin	+1pp
Research & development	−0	5%	+0pp
SG&A	−0.4	40%	−1pp
Other	−0	5%	+0pp
Operating profit	0.2	18% margin	+1pp
Tax	−0.1
Net profit	0.1	9%	−1pp

All figures in billions of U.S. dollars, for Q1 FY25 (period ends Jan 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1	100%	+4%
United States	0.5	50%
Europe	0.3	30%
Rest of world	0.2	20%
Cost of revenue	−0.3	30%
Gross profit	0.7	68% margin	+1pp
Research & development	−0	4%	+0pp
SG&A	−0.4	40%	−1pp
Other	−0	5%	+0pp
Operating profit	0.2	19% margin	+2pp
Net profit	0.1	11%	+2pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26	Apr 30, 2026	Jun 5, 2026	$1.1B	+8%	0%	$-0.1B	-7%
Q3 FY25	May 1 – Jul 31, 2025	Aug 28, 2025	$1.1B	+6%	18%	$0.1B	9%
Q2 FY25	Feb 1 – Apr 30, 2025	May 30, 2025	$1B	+6%	20%	$0.1B	9%
Q1 FY25	Nov 1, 2024 – Jan 31, 2025	Mar 7, 2025	$1B	+4%	20%	$0.1B	11%